South west of England support group makes donation to specialist cancer charity

SWASAG, the south west Asbestos Support Awareness Group, has donated £10,000 to national asbestos-related cancer charity, Mesothelioma UK. The donation is the result of two years’ fundraising during the Covid-19 pandemic.

Mesothelioma is a type of lung cancer primarily caused by exposure to asbestos and affects approximately 2,500 people in the UK each year. Mesothelioma UK relies on donations, grants and fundraisers to deliver its services supporting patients and families around the country.

Steve Jones, Chairman of SWASAG said: “We are delighted to be in a position where we can  support Mesothelioma UK. SWASAG covers a geographical area that is a ‘hotspot’ for mesothelioma and this insidious disease affects many lives in the Peninsula.

“As a group we are very grateful to Mesothelioma UK for their tireless work in highlighting the dangers of asbestos, promoting clinical trials and supplying our expert nurse, and we will continue to do anything we can to support their efforts.”

A cheque for the £10,000 was presented to Christine Jones, Mesothelioma UK Clinical Nurse Specialist for the Peninsula Cancer Alliance region, at one of SWASAG’s regular support group meetings.

Christine commented: “We’re extremely grateful for the donation of £10,000 from SWASAG. We have strong relationships with local support groups and working with each other means better overall support for our patients and families. Donations like this are vital to us and we really appreciate it. We will ensure that the money is spent in the best way possible to make a real difference to people affected by mesothelioma.”

About SWASAG:
SWASAG is an independent, registered charity that is 100% dedicated to helping people living with asbestos-related conditions across the south west of England, including Devon and Cornwall. Our aim is to provide all the help, practical advice and support to those diagnosed with an asbestos-related disease, and their families.

Look out for Patient and Carer Day 2022

Each year, Mesothelioma UK holds its annual patient and carer day - a day of learning, shared experiences and a chance to come together. The event hosts a number of key speakers discussing, surgery, new treatment and trials and many other concerns or questions that...

Access to immunotherapy update

As you may be aware from previous issues of our magazine, first line immunotherapy (nivolumab and ipilimumab) for the treatment of mesothelioma is currently under consideration by the National Institute for Health and Care Excellence (NICE) following the results of...

Mesothelioma UK partners with Healthinote

Mesothelioma UK has joined Healthinote, an online digital platform allowing doctors, nurses and pharmacists to find and share reliable health information with their patients. Used by over 3,000 GP practices in the UK, Heathinote enables people to be given an...